查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2016042

即時分子診斷市場報告：按產品/服務、技術、應用、最終用戶和地區分類（2026-2034 年）

Point of Care Molecular Diagnostics Market Report by Product and Service, Technology, Application, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球即時分子診斷市場規模達44億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到90億美元，2026年至2034年的複合年成長率（CAGR）為8.09%。北美地區憑藉其完善的醫療基礎設施、強大的行業領導者以及創新診斷技術的高普及率，正引領市場成長。感染疾病率的上升和醫療設施的快速發展也顯著推動了市場成長。

即時分子診斷（POC）是指醫師為診斷和檢測感染疾病而進行的檢測。這些檢測包括血液學檢測、懷孕檢測、不孕症檢測、感染疾病、尿液檢查以及心臟代謝和血糖監測設備。 POC分子診斷廣泛用於病原體鑑定、微量殘存疾病（MRD）和胃腸道疾病的診斷、血紅蛋白和糞便潛血的監測，以及確定患者對特定藥物或藥物類別的代謝能力。這些檢測能夠更快獲得結果，減少誤診併發症，並改善感染控制。因此，POC分子診斷廣泛應用於醫院、加護病房（ICU）、實驗室、診所、分散式檢查和居家醫療機構。

即時分子診斷市場趨勢：

慢性病和感染疾病率上升

癌症、糖尿病、心血管疾病和感染疾病爆發等疾病的盛行率不斷上升，凸顯了快速、精準診斷技術的必要性。即時分子診斷具有快速識別的優勢，能夠實現及時的醫療干預和高效的疾病管理。這對於延緩疾病進展、提高患者存活率和控制感染疾病傳播尤為重要。此外，即時分子診斷能夠追蹤疾病進展和治療效果，進而改善整體醫療保健管理。隨著人口老化和不斷變化的健康風險增加，醫療保健系統對診斷服務的需求也隨之成長，即時分子診斷提供了一種擴充性且有效的解決方案。持續應對複雜健康問題的需求正在推動其應用，而疾病盛行率的上升則是市場成長的主要驅動力。

人口老化的過程

老年人罹患慢性病、感染疾病和老齡化相關疾病的風險更高，因此快速且準確的診斷對於有效治療至關重要。隨著醫療衛生系統為應對日益成長的需求做好準備，快速、準確且易於獲取的診斷工具對於促進早期發現和介入至關重要。世界衛生組織（世衛組織）指出，到2030年，全球六分之一的人口將超過60歲，預計2050年，數字將達到21億。此外，80歲及以上人口的數量預計將增加兩倍，到2050年達到4.26億。這種人口結構的變化預計將給醫療衛生系統帶來沉重負擔，凸顯了對尖端即時分子診斷技術的迫切需求，以改善患者預後、減輕醫院負擔並促進高效分散的醫療服務。

分散式醫療服務的重要性

隨著醫療保健需求的成長，尤其是在農村、偏遠和資源匱乏地區，無需依賴集中式檢測機構即可提供快速、準確、可靠結果的診斷工具變得日益重要。即時分子診斷透過提供快速的現場檢測方案，有效應對了這項挑戰，顯著減少了檢體運輸延誤、儲存問題以及集中處理造成的延誤等物流障礙。這種分散化確保患者能夠更早獲得介入措施和更精準的治療方案，從而改善醫療保健效果並減輕疾病負擔。此外，隨著對成本控制和營運效率的日益重視，醫療機構正在利用這些技術來改善病患管理、提高工作流程效率並最大限度地利用現有資源。分散式醫療服務透過提高醫療服務的可近性、加快檢測速度和最大限度地減少系統性低效，持續成長要素。

即時分子診斷市場成長要素：

對價格合理且準確的診斷解決方案的需求

隨著醫療系統努力確保可靠檢測的廣泛普及，經濟實惠的分子診斷平台的重要性日益凸顯。這些解決方案兼具高精度和低營運成本，使得診所、藥局甚至家庭環境都能更方便地進行檢測。經濟實惠的診斷技術簡化了工作流程，無需複雜的樣本製備，也減少了對專業培訓的需求，從而縮短了結果報告時間。這種兼顧準確度和成本效益的優勢將逐步取代可靠性較低的檢測方法，最終改善患者預後，並提升疾病管理水準。隨著醫療系統日益重視以價值為導向的醫療服務，對經濟高效且精準的診斷的需求成為市場成長的關鍵驅動力。 2024年，3EO Health在美國推出了一款無需CLIA照護現場分子診斷平台，提供價格低於20美元的COVID-19檢測，且無需檢體製備。這款緊湊型3TR系統可在診所和家庭環境中實現經濟高效的檢測，旨在以具有分子級精準度的檢測方法取代抗原檢測。

攜帶式診斷技術的進步

與傳統實驗室相比，緊湊易用的設備能夠實現更可靠的檢測，從而擴大都市區地區獲得關鍵診斷服務的途徑。這些進步能夠提供快速且準確的檢測結果，支援快速的臨床決策，並最大限度地減少集中檢測中心的等待時間。便攜性的提升使醫護人員能夠在各種場所進行檢測，從社區醫療機構到偏遠診所，從而擴大醫療服務的覆蓋範圍，並改善疾病控制效果。易於部署和低基礎設施要求使得攜帶式診斷設備用途廣泛。攜帶式分子診斷技術的創新提高了效率、擴充性和可及性，推動了市場對全球醫療服務進步的貢獻，並確保了關鍵檢測的公平獲取。 2024年，Molbio在印度提供的照護現場分子診斷平台Truenat因其在結核病控制方面發揮的作用，在第77屆世界衛生大會上獎勵。這款攜帶式電池供電的PCR設備可在1小時內提供快速、高度準確的檢測結果，並在印度廣泛部署。

與數位健康和​​數據分析的整合

照護現場分子診斷、數位健康平台和先進數據分析的結合正在推動市場成長。雲端資料儲存、行動醫療健康應用和電子健康記錄 (EHR) 整合等現代連接功能，實現了在整個醫療保健網路中無縫傳輸、存取和監測診斷結果。這種互通性使醫療專業人員能夠存取即時數據、監測疾病進展並有效率地制定個人化治療方案，從而增強臨床決策能力。此外，分析洞察透過識別疾病趨勢、預測潛在疫情爆發和最佳化醫療資源分配，為人群健康管理提供支援。將診斷技術與遠端醫療服務和遠距監測系統結合，還能使農村和醫療資源匱乏地區的患者獲得快速、準確和持續的醫療服務。這個整合生態系統有助於提高診斷準確性和營運效率，增強患者參與度和治療依從性，從而推動即時分子診斷在全球範圍內的普及應用。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球即時分子診斷市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品及服務分類

  • 檢測和試劑盒
  • 儀器和分析設備
  • 軟體和服務

第7章 市場區隔：依技術分類

  • 聚合酵素鏈鎖反應（PCR）
  • 雜合反應
  • DNA定序
  • 微陣列
  • 恒溫核酸增幅技術（INAAT）
  • 其他

第8章 市場區隔：依應用領域分類

  • 感染疾病
  • 腫瘤學
  • 血液學
  • 產前檢查
  • 內分泌學
  • 其他

第9章 市場區隔：依最終用戶分類

  • 診所
  • 醫院及重症監護室
  • 研究機構
  • 其他

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • binx health, inc.
    • Cepheid（Danaher Corporation）
    • Co-Diagnostics Inc.
    • F. Hoffmann-La Roche Ltd
    • Meridian Bioscience
    • Molbio Diagnostics Limited
    • QuantuMDx Group Limited
    • Thermo Fisher Scientific Inc.
    • Visby Medical Inc.
Product Code: SR112026A6271

The global point of care molecular diagnostics market size reached USD 4.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 9.0 Billion by 2034, exhibiting a growth rate (CAGR) of 8.09% during 2026-2034. North America dominates the market owing to its improved healthcare infrastructure, strong presence of key industry players, and high adoption of innovative diagnostic technologies. The increasing incidence of infectious diseases paired with rapid development in healthcare facilities is significantly driving the market growth.

Point-of-care (POC) molecular diagnostics refer to tests performed by physicians to diagnose and detect infectious diseases. It includes hematology, pregnancy, fertility, infectious diseases, urinalysis testing kits, and cardiometabolic and glucose monitoring devices. POC molecular diagnostics is widely used for identifying infectious agents, minimal residual disease, and gastrointestinal disorders, monitoring hemoglobin and fecal occult blood, and determining a patient's ability to metabolize a drug or drug class. These tests offer faster results, reduce complications associated with mistreatment, and improve infection control measures. As a result, POC molecular diagnostics finds extensive applications in hospitals, intensive care units (ICUs), research institutes, clinics, decentralized laboratories, and homecare facilities.

POINT OF CARE MOLECULAR DIAGNOSTICS MARKET TRENDS:

Rising Prevalence of Chronic and Infectious Diseases

The rising prevalence of diseases like cancer, diabetes, cardiovascular issues, and infectious outbreaks underscores the need for swift and precise diagnostic techniques. Point-of-care molecular diagnostics offer the benefit of prompt identification, allowing for timely medical action and efficient disease management. This is especially crucial for slowing disease progression, enhancing patient survival rates, and limiting the transmission of infectious diseases. In addition, the capability of point of care molecular diagnostics to track disease advancement and treatment efficacy enhances overall care management. With healthcare systems experiencing increased demand for diagnostic services from aging populations and changing health risks, point of care molecular diagnostics offer a scalable and effective solution. The ongoing necessity to tackle intricate health issues reinforces their acceptance, positioning disease prevalence as a key factor impelling the market growth.

Growing Geriatric Population

Elderly people are at greater risk for chronic illnesses, infectious diseases, and age-associated conditions, necessitating prompt and accurate diagnostics for effective treatment. As healthcare systems gear up to handle these increasing demands, the necessity for swift, precise, and readily available diagnostic tools is essential to facilitate early detection and intervention. The World Health Organization (WHO) emphasizes that by 2030, one in six people globally will be 60 years or older, and this figure is expected to reach 2.1 billion by 2050. Furthermore, the number of individuals aged 80 and over is predicted to grow three times, totaling 426 million by 2050. This demographic change is expected to exert significant strain on healthcare systems, highlighting the need for cutting-edge point-of-care molecular diagnostics to improve patient results, lessen hospital pressures, and facilitate effective, decentralized healthcare provision.

Emphasis on Decentralized Healthcare Delivery

With the growing healthcare needs, especially in rural, isolated, and resource-constrained areas, the need for diagnostic tools that can provide quick, accurate, and dependable results without relying on centralized lab facilities is becoming more vital. Point of care molecular diagnostics effectively tackle this issue by offering quick, on-site testing options that greatly minimize logistical obstacles like delays from sample transport, storage problems, and centralized processing delays. This decentralization guarantees that patients access earlier interventions and more precise treatment paths, leading to enhanced healthcare results and lower disease burdens. Additionally, as the focus on cost control and operational effectiveness grows, healthcare organizations are utilizing these technologies to improve patient management, boost workflow efficiency, and make the most of existing resources. Decentralized healthcare delivery remains a key growth factor for the point-of-care molecular diagnostics market by enhancing accessibility, speeding up turnaround times, and minimizing systemic inefficiencies.

POINT OF CARE MOLECULAR DIAGNOSTICS MARKET GROWTH DRIVERS:

Demand for Affordable and Accurate Diagnostic Solutions

As healthcare systems strive to ensure broad access to dependable testing, affordable molecular platforms are gaining significance. These solutions merge high precision with lower operational costs, enabling wider accessibility in clinics, pharmacies, and even home environments. Affordable diagnostic technologies simplify workflows and decrease turnaround times by removing intricate sample preparation and lessening the requirement for specialized training. This equilibrium between accuracy and cost-effectiveness facilitates the substitution of unreliable testing techniques, leading to enhanced patient results and superior disease management. As healthcare systems focus on value-based care, the need for cost-effective and precise diagnostics is a vital factor propelling the market growth. In 2024, 3EO Health launched its CLIA-waived point-of-care molecular diagnostics platform in the US, offering COVID-19 testing under $20 with no sample prep. The compact 3TR system enabled affordable, high-efficiency testing in clinics and homes, aiming to replace antigen tests with molecular accuracy.

Advancements in Portable Diagnostic Technologies

Small and easy-to-use devices are facilitating dependable testing beyond conventional lab environments, broadening access to essential diagnostic services in urban and rural regions. These advancements deliver quick, precise outcomes, aiding prompt clinical choices and minimizing the wait times linked to centralized testing centers. Improved portability enables healthcare professionals to perform testing in various settings, ranging from community health facilities to distant clinics, thus expanding healthcare access and enhancing disease management results. The simplicity of deployment, paired with low infrastructure needs, enables portable diagnostics to be highly versatile for extensive usage. Enhancing efficiency, scalability, and accessibility, innovations in portable molecular diagnostics bolster the market's contribution to advancing global healthcare delivery and guaranteeing fair access to vital testing. In 2024, India's Truenat, a point-of-care molecular diagnostics platform by Molbio, was recognized at the 77th World Health Assembly for its role in combating TB. The portable, battery-operated PCR device delivers rapid, high-accuracy results in under an hour and is widely deployed across India.

Integration with Digital Health and Data Analytics

The combination of point-of-care molecular diagnostics with digital health platforms and sophisticated data analytics is contributing to the market growth. Contemporary connectivity capabilities, such as cloud data storage, mobile health apps, and electronic health record (EHR) integration, enable the smooth transfer, access, and monitoring of diagnostic results throughout healthcare networks. This interoperability enhances clinical decision-making by enabling healthcare providers to obtain real-time data, monitor disease progression, and more efficiently coordinate personalized treatment plans. Additionally, analytics-driven insights support population health management by identifying disease trends, predicting potential outbreaks, and improving the allocation of healthcare resources. Furthermore, integrating diagnostic technologies with telemedicine services and remote monitoring systems allows patients in rural and underserved regions to access prompt, precise, and ongoing care. This cohesive ecosystem promotes enhanced precision and operational effectiveness, alongside increased patient involvement and adherence, supporting the adoption of point-of-care molecular diagnostics globally.

KEY MARKET SEGMENTATION:

Breakup by Product and Service:

  • Assays and Kits
  • Instruments and Analyzers
  • Software and Services

Breakup by Technology:

  • Polymerase Chain Reaction (PCR)
  • Hybridization
  • DNA sequencing
  • Microarray
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Others

Breakup by Application:

  • Infectious Diseases
  • Oncology
  • Hematology
  • Prenatal Testing
  • Endocrinology
  • Others

Breakup by End User:

  • Physicians' Offices
  • Hospitals and ICUs
  • Research Institutes
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the global point of care molecular diagnostics market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • binx health, inc.
  • Cepheid (Danaher Corporation)
  • Co-Diagnostics Inc.
  • F. Hoffmann-La Roche Ltd
  • Meridian Bioscience
  • Molbio Diagnostics Limited
  • QuantuMDx Group Limited
  • Thermo Fisher Scientific Inc.
  • Visby Medical Inc.

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What was the size of the global point of care molecular diagnostics market in 2025?

2. What is the expected growth rate of the global point of care molecular diagnostics market during 2026-2034?

3. What are the key factors driving the global point of care molecular diagnostics market?

4. What has been the impact of COVID-19 on the global point of care molecular diagnostics market?

5. What is the breakup of the global point of care molecular diagnostics market based on the product and service?

6. What is the breakup of the global point of care molecular diagnostics market based on the technology?

7. What is the breakup of the global point of care molecular diagnostics market based on application?

8. What are the key regions in the global point of care molecular diagnostics market?

9. Who are the key players/companies in the global point of care molecular diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Point of Care Molecular Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product and Service

  • 6.1 Assays and kits
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments and Analyzers
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Polymerase Chain Reaction (PCR)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Hybridization
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 DNA sequencing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Microarray
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Infectious Diseases
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oncology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hematology
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Prenatal Testing
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Endocrinology
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Physicians' Offices
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospitals and ICUs
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Becton, Dickinson and Company
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 binx health, inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Cepheid (Danaher Corporation)
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Co-Diagnostics Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 F. Hoffmann-La Roche Ltd
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 Meridian Bioscience
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Molbio Diagnostics Limited
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 QuantuMDx Group Limited
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Thermo Fisher Scientific Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Visby Medical Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Point of Care Molecular Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Point of Care Molecular Diagnostics Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Point of Care Molecular Diagnostics Market: Breakup by Product and Service (in %), 2025
  • Figure 5: Global: Point of Care Molecular Diagnostics Market: Breakup by Technology (in %), 2025
  • Figure 6: Global: Point of Care Molecular Diagnostics Market: Breakup by Application (in %), 2025
  • Figure 7: Global: Point of Care Molecular Diagnostics Market: Breakup by End User (in %), 2025
  • Figure 8: Global: Point of Care Molecular Diagnostics Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Point of Care Molecular Diagnostics (Assays and Kits) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Point of Care Molecular Diagnostics (Assays and Kits) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Point of Care Molecular Diagnostics (Instruments and Analyzers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Point of Care Molecular Diagnostics (Instruments and Analyzers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Point of Care Molecular Diagnostics (Software and Services) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Point of Care Molecular Diagnostics (Software and Services) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Point of Care Molecular Diagnostics (Polymerase Chain Reaction) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Point of Care Molecular Diagnostics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Point of Care Molecular Diagnostics (Hybridization) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Point of Care Molecular Diagnostics (Hybridization) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Point of Care Molecular Diagnostics (DNA sequencing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Point of Care Molecular Diagnostics (DNA sequencing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Point of Care Molecular Diagnostics (Microarray) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Point of Care Molecular Diagnostics (Microarray) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Point of Care Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Point of Care Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Point of Care Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Point of Care Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Point of Care Molecular Diagnostics (Infectious Diseases) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Point of Care Molecular Diagnostics (Infectious Diseases) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Point of Care Molecular Diagnostics (Oncology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Point of Care Molecular Diagnostics (Oncology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Point of Care Molecular Diagnostics (Hematology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Point of Care Molecular Diagnostics (Hematology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Point of Care Molecular Diagnostics (Prenatal Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Point of Care Molecular Diagnostics (Prenatal Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Point of Care Molecular Diagnostics (Endocrinology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Point of Care Molecular Diagnostics (Endocrinology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Global: Point of Care Molecular Diagnostics (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Global: Point of Care Molecular Diagnostics (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Global: Point of Care Molecular Diagnostics (Physicians' Offices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Global: Point of Care Molecular Diagnostics (Physicians' Offices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Global: Point of Care Molecular Diagnostics (Hospitals and ICUs) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Global: Point of Care Molecular Diagnostics (Hospitals and ICUs) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Global: Point of Care Molecular Diagnostics (Research Institutes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Global: Point of Care Molecular Diagnostics (Research Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Global: Point of Care Molecular Diagnostics (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Global: Point of Care Molecular Diagnostics (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: North America: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: North America: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: United States: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: United States: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Canada: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Canada: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Asia-Pacific: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Asia-Pacific: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: China: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: China: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Japan: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Japan: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: India: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: India: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: South Korea: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: South Korea: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Australia: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Australia: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Indonesia: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Indonesia: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Others: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Others: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Europe: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Europe: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Germany: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Germany: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: France: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: France: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: United Kingdom: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: United Kingdom: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Italy: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Italy: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Spain: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Spain: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Russia: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: Russia: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 83: Others: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 84: Others: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 85: Latin America: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 86: Latin America: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 87: Brazil: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 88: Brazil: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 89: Mexico: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 90: Mexico: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 91: Others: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 92: Others: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 93: Middle East and Africa: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 94: Middle East and Africa: Point of Care Molecular Diagnostics Market: Breakup by Country (in %), 2025
  • Figure 95: Middle East and Africa: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 96: Global: Point of Care Molecular Diagnostics Industry: SWOT Analysis
  • Figure 97: Global: Point of Care Molecular Diagnostics Industry: Value Chain Analysis
  • Figure 98: Global: Point of Care Molecular Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Point of Care Molecular Diagnostics Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Product and Service (in Million USD), 2026-2034
  • Table 3: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 4: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 5: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 6: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Point of Care Molecular Diagnostics Market: Competitive Structure
  • Table 8: Global: Point of Care Molecular Diagnostics Market: Key Players